Title:
【発明の名称】三環式誘導体、それらを含有する薬学的組成物
Document Type and Number:
Japanese Patent JP2793915
Kind Code:
B2
Abstract:
Disclosed are compounds of Formula I: (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: R3 is alkyl, alkenyl, alkynyl, aryl, alkaryl, aralkyl, cycloalkyl, acyloxymethyl, alkoxy, alkoxymethyl, or alkyl substituted with cycloalkyl; R4 is H, alkyl, alkenyl, alkoxy, or -OH. Also disclosed are pharmaceutical compositions containing compounds of Formula I, methods for inhibiting tumor necrosis factor- alpha and methods for treating septic shock, inflammation, or allergic disease by administering a compound of Formula I.
Inventors:
TEIN HOORIN SHII
SOROMON DANIERU ERU
FURIARII RICHAADO JEI
BIRAANI FURANKU JEI
PIUINSUKII JON JEI
RII JOO EFU
SEIRU BERA EI
JAKUEI JEEMUZU PII
BASHI DEIRU BII
SOROMON DANIERU ERU
FURIARII RICHAADO JEI
BIRAANI FURANKU JEI
PIUINSUKII JON JEI
RII JOO EFU
SEIRU BERA EI
JAKUEI JEEMUZU PII
BASHI DEIRU BII
Application Number:
JP51622395A
Publication Date:
September 03, 1998
Filing Date:
December 05, 1994
Export Citation:
Assignee:
SHEERINGU PURAU CORP
International Classes:
A61K31/125; A61K31/135; A61K31/18; A61K31/195; A61K31/335; A61K31/40; A61K31/4025; A61K31/403; A61K31/4035; A61K31/404; A61K31/44; A61K31/443; A61P29/00; A61P31/04; A61P35/00; A61P37/08; A61P43/00; C07C33/38; C07C45/44; C07C47/235; C07D295/02; C07C47/453; C07C69/608; C07C69/618; C07C211/26; C07C211/32; C07C215/42; C07C217/52; C07C229/14; C07C233/05; C07C233/18; C07C233/73; C07C251/40; C07C271/10; C07C271/12; C07C271/16; C07C311/03; C07C311/04; C07C311/17; C07D207/16; C07D209/08; C07D209/44; C07D209/48; C07D213/89; C07D221/16; C07D261/02; C07D295/03; C07D295/084; C07D313/12; C07D405/06; (IPC1-7): C07C217/52; A61K31/135; A61K31/195; A61K31/335; A61K31/40; C07C229/14; C07C233/05; C07C233/73; C07C251/40; C07C271/12; C07C311/03; C07D261/02; C07D313/12
Domestic Patent References:
JP4225953A |
Other References:
Journal of Medicinal Chemistry,1972,15(6),665−673
Journal of Medicinal Chemistry,1972,15(7),750−754
Journal of Medicinal Chemistry,1972,15(7),750−754
Attorney, Agent or Firm:
Shusaku Yamamoto